To make a randomized comparison of 2 consolidation treatment options ( two patient groups ) : 2 cycles of cytarabine in average ( Ig/m2 in Group 2 ) and standard ( 100 mg/mi2 in Group 1 ) doses in combination with idarubicin ( 8-12 mg/m2 ) and mitoxantrone ( 10 mg/m2 ) , after two 7 +3 induction cycles of daunorubicin ( 60 mg/mi2 ) and subsequent 6 cycles of maintenance therapy .